[HTML] mdpi.com

[HTML][HTML] The past, present, and future of clinically applied chimeric antigen receptor-T-cell therapy

Y Fujiwara, T Kato, F Hasegawa, M Sunahara… - Pharmaceuticals, 2022 - mdpi.com
Immunotherapy represents the fourth pillar of cancer therapy after surgery, chemotherapy,
and radiation. Chimeric antigen receptor (CAR)-T-cell therapy is an artificial immune cell …
被引用次数：9 相关文章

The Past, Present, and Future of Clinically Applied Chimeric Antigen Receptor-T-Cell Therapy

Y Fujiwara, T Kato, F Hasegawa… - Pharmaceuticals …, 2022 - pubmed.ncbi.nlm.nih.gov
Immunotherapy represents the fourth pillar of cancer therapy after surgery, chemotherapy,
and radiation. Chimeric antigen receptor (CAR)-T-cell therapy is an artificial immune cell …

The Past, Present, and Future of Clinically Applied Chimeric Antigen Receptor-T-Cell Therapy.

Y Fujiwara, T Kato, F Hasegawa… - Pharmaceuticals …, 2022 - search.ebscohost.com
Immunotherapy represents the fourth pillar of cancer therapy after surgery, chemotherapy,
and radiation. Chimeric antigen receptor (CAR)-T-cell therapy is an artificial immune cell …

The Past, Present, and Future of Clinically Applied Chimeric Antigen Receptor-T-Cell Therapy.

Y Fujiwara, T Kato, F Hasegawa… - Pharmaceuticals …, 2022 - europepmc.org
Immunotherapy represents the fourth pillar of cancer therapy after surgery, chemotherapy,
and radiation. Chimeric antigen receptor (CAR)-T-cell therapy is an artificial immune cell …

The Past, Present, and Future of Clinically Applied Chimeric Antigen Receptor-T-Cell Therapy

Y Fujiwara, T Kato, F Hasegawa, M Sunahara… - …, 2022 - search.proquest.com
Immunotherapy represents the fourth pillar of cancer therapy after surgery, chemotherapy,
and radiation. Chimeric antigen receptor (CAR)-T-cell therapy is an artificial immune cell …
[HTML] nih.gov

[HTML][HTML] The Past, Present, and Future of Clinically Applied Chimeric Antigen Receptor-T-Cell Therapy

Y Fujiwara, T Kato, F Hasegawa, M Sunahara… - …, 2022 - ncbi.nlm.nih.gov
Immunotherapy represents the fourth pillar of cancer therapy after surgery, chemotherapy,
and radiation. Chimeric antigen receptor (CAR)-T-cell therapy is an artificial immune cell …

The Past, Present, and Future of Clinically Applied Chimeric Antigen Receptor-T-Cell Therapy.

Y Fujiwara, T Kato, F Hasegawa… - Pharmaceuticals …, 2022 - europepmc.org
Immunotherapy represents the fourth pillar of cancer therapy after surgery, chemotherapy,
and radiation. Chimeric antigen receptor (CAR)-T-cell therapy is an artificial immune cell …